Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-11-09 Purchase | 2023-11-09 4:35 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,560,000 | $9 | $14,040,000 | 6,922,870 (Indirect) | View |
2023-06-20 Purchase | 2023-06-20 4:30 pm | Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 4,760,000 | $22.66 | $107,861,600 | 13,959,973 (Indirect) | View |
2022-12-05 Purchase | 2022-12-07 4:30 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,250,000 | $12 | $15,000,000 | 5,362,870 (Indirect) | View |
2021-11-02 Purchase | 2021-11-04 4:44 pm | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 1,785,000 | $14 | $24,990,000 | 4,112,870 (Indirect) | View |
2021-03-08 Sale | 2021-03-10 7:45 pm | Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Matrix Capital Management Company LP See Remarks | 806,000 | $39.99 | $32,228,827 | 12,310,594 (Indirect Direct) | View |
2020-07-20 Sale | 2020-07-22 4:15 pm | Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Matrix Capital Management Company LP See Remarks 10% Owner | 2,000,000 | $40 | $80,000,000 | 13,115,090 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2022-06-03 10:54 am | N/A N/A | Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 0 | $0 | 9,199,973 (Indirect) | View |
2021-11-02 Conversion | 2021-11-04 4:44 pm | N/A N/A | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 2,327,870 | $0 | 4,112,870 (Indirect) | View |
Ownership | 2021-10-28 8:39 pm | N/A N/A | Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner | 0 | $0 | 2,327,870 (Indirect) | View |
Ownership | 2020-04-03 6:00 pm | N/A N/A | Zentalis Pharmaceuticals LLC | ZNTL | GOEL DAVID E. Matrix Capital Management Company LP Director 10% Owner | 0 | $0 | 3,821,739 (Indirect) | View |
2020-01-24 Conversion | 2020-01-28 4:15 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | GOEL DAVID E. Matrix Capital Management Company LP See Remarks 10% Owner | 2,217,101 | $26.5 | 15,115,090 (Indirect) | View |